DJIA 16,563.30 -317.06 -1.88%
NASDAQ 4,369.77 -93.13 -2.09%
S&P 500 1,930.67 -39.40 -2.00%
market minute promo

Allergan, Inc. (NYSE: AGN)

165.86 -6.31 (-3.66%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

AGN $165.86 -3.66%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $168.93
Previous Close $172.17
Daily Range $164.02 - $170.23
52-Week Range $86.95 - $174.49
Market Cap $49.4B
P/E Ratio 36.55
Dividend (Yield) $0.20 (0.1%)
Ex-Dividend Date
Dividend Pay Date
08/13/14
09/05/14
Volume 5,306,036
Average Daily Volume 1,803,349
Current FY EPS $5.79

Sector

Healthcare

Industry

Drugs

Allergan, Inc. (AGN) Description

A technology-driven, global health care company which discovers, develops and commercializes pharmaceutical and medical device products for markets such as ophthalmic, neurological, medical aesthetics, medical dermatological etc. Website: http://www.allergan.com/

News & Commentary Rss Feed

Why Is Allergan Beating the S&P 500?

Allergan (NYSE: AGN) is up versus the S&P 500 in 2014 -- especially since its results were released in early February. Here's why that is.

Impax Shares Plunge Post FDA Inspection of Taiwan Facility - Analyst Blog

McKesson Beats on Q1 Earnings & Revenues, Increases Guidance - Analyst Blog

McKesson Beats on Q1 Earnings & Revenues, Increases Guidance - Analyst Blog

Update: Looks Like Bill Ackman Does Not Have Enough Allergan Shareholder Votes

Top 4 NYSE Stocks In The Drug Manufacturers-Other Industry With The Highest EPS

Today's Momo Momentum Stock To Watch: Allergan (AGN)

Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog

Merck (MRK) Tops Q2 Earnings Expectations on Cost Cuts - Analyst Blog

Pfizer Beats on Q2 Earnings, Revs Despite Generic Pressures - Analyst Blog

Novartis Division Gets European Approval for Simbrinza - Analyst Blog

Novartis Division Gets European Approval for Simbrinza - Analyst Blog

Celgene Beats Q2 Earnings Estimates on Strong Revlimid Sales - Analyst Blog

Bayer/Amgen's Nexavar Does Not Show Resilience in Study - Analyst Blog

See More AGN News...

AGN's Top Competitors

AGN $165.86 (-3.66%)
Current stock: AGN
JNJ $100.09 (-2.16%)
Current stock: JNJ
NVS $86.94 (-1.70%)
Current stock: NVS
RHHBY $36.33 (-1.36%)
Current stock: RHHBY